AMGEN INC. $300,000,000 SENIOR FLOATING RATE NOTES DUE 2019 $300,000,000 SENIOR FLOATING RATE NOTES DUE 2020 $700,000,000 1.900% SENIOR NOTES DUE 2019 $700,000,000 2.200% SENIOR NOTES DUE 2020 $1,500,000,000 2.650% SENIOR NOTES DUE 2022 Underwriting...Underwriting Agreement • May 11th, 2017 • Amgen Inc • Biological products, (no disgnostic substances) • New York
Amgen Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of $300,000,000 principal amount of its Senior Floating Rate Notes due 2019 (the “2019 Floating Rate Notes”), $300,000,000 principal amount of its Senior Floating Rate Notes due 2020 (the “2020 Floating Rate Notes”), $700,000,000 principal amount of its 1.900% Senior Notes due 2019 (the “2019 Fixed Rate Notes”), $700,000,000 principal amount of its 2.200% Senior Notes due 2020 (the “2020 Fixed Rate Notes”), and $1,500,000,000 principal amount of its 2.650% Senior Notes due 2022 (the “2022 Fixed Rate Notes”), and together with the 2019 Floating Rate Notes, the 2020 Floating Rate Notes, the 2019 Fixed Rate Notes and the 2020 Notes, the “Securities”) to be issued pursuant to the provisions of an Indenture dated as of May 22, 2014 (the “Indenture”), between the Company and The Bank
